Chargement en cours...

Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study

Objective To examine clinical effectiveness and safety of apixaban 2.5 mg, dabigatran 110 mg, and rivaroxaban 15 mg compared with warfarin among patients with atrial fibrillation who had not previously taken an oral anticoagulant. Design Propensity weighted (inverse probability of treatment weighted...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:BMJ
Auteurs principaux: Nielsen, Peter Brønnum, Skjøth, Flemming, Søgaard, Mette, Kjældgaard, Jette Nordstrøm, Lip, Gregory Y H, Larsen, Torben Bjerregaard
Format: Artigo
Langue:Inglês
Publié: BMJ Publishing Group Ltd. 2017
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5421446/
https://ncbi.nlm.nih.gov/pubmed/28188243
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmj.j510
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!